Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Clinical Pharmacology|November 28, 2017
Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative ColitisXiaohui Wei, Leonid Gibiansky, Yehong Wang, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 16, 2016
Mass cytometry panel optimization through the designed distribution of signal interferenceChikara Takahashi, Amelia Au-Yeung, Franklin Fuh, et al.Cytometry. Part B, Clinical Cytometry|March 23, 2026
Establishing a flow cytometry-based tissue receptor occupancy assay for an anti-oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel diseaseDivya Jha, Hailey Garma, Sean Lear, et al.Inflammatory Bowel Diseases|December 1, 2021
Pharmacokinetics, Pharmacodynamics, and Safety of Etrolizumab in Children With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease: Results from a Phase 1 Randomized TrialWenhui Zhang, Astrid Scalori, Franklin Fuh, et al.Frontiers in Pharmacology|February 19, 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel DiseaseCharlotte Lichnog, Sha Klabunde, Emily Becker, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 25, 2021
Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel DiseaseMary E Keir, Franklin Fuh, Ryan Ichikawa, et al.Molecular Cancer Therapeutics|April 20, 2013
DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphomaDongwei Li, Kirsten Achilles Poon, Shang-Fan Yu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
CS1, a potential new therapeutic antibody target for the treatment of multiple myelomaEric D Hsi, Roxanne Steinle, Balaji Balasa, et al.Pageof 1